Heramed Limited

Heramed Limited company information, Employees & Contact Information

Explore related pages

Related company profiles:

HeraMED Limited (ASX:HMD) is an innovative medical data and technology company leading the digital transformation of the prenatal and postpartum experience through its revolutionary remote monitoring and hybrid maternity care platform. HeraMED’s state of the art in-home fetal and maternal heart rate monitor, HeraBEAT, is medically accurate, scientifically optimized and smartphone-based. It provides seamless data sharing of maternal and fetal vital signs with medical professionals via the company’s platform HeraCARE. HeraCARE is a complete remote maternity care platform designed to power personalized, safe, proactive care for both patients and providers. The hybrid care model made possible by HeraCARE makes remote monitoring of vital signs including blood pressure, weight, FHR, mood, and more possible. Patients and providers experience action-driven alerts when any measurement falls outside 'normal' range. Plus, patients have 24/7 access to comprehensive educational content, lifestyle guidance, pregnancy management tools, and support. HeraMED’s technology has been recognised by major medical institutions, with collaborations underway with the Mayo Clinic and the Sheba Medical Center, two of the world’s top 10 hospitals. Through its partnerships and investment in R&D, HeraMED continues to optimise and develop the next generation of its home-oriented monitoring technology. To learn more, please visit: www.hera-med.com/

Company Details

Employees
19
Founded
-
Address
Melbourne, Au
Industry
Wellness And Fitness Services
NAICS
Fitness and Recreational Sports Centers
HQ
Melbourne
Looking for a particular Heramed Limited employee's phone or email?

Heramed Limited Questions

News

Garmin Partners with HeraMED to Transform Remote Maternity Care - Garmin Rumors

Garmin Partners with HeraMED to Transform Remote Maternity Care Garmin Rumors

HeraMED Signs Strategic Collaboration Agreement with Garmin Health - Investing News Network

HeraMED Signs Strategic Collaboration Agreement with Garmin Health Investing News Network

HeraMED Partners with Garmin Health to Advance Remote Pregnancy Monitoring - Femtech Insider

HeraMED Partners with Garmin Health to Advance Remote Pregnancy Monitoring Femtech Insider

HeraMED Ltd. Issues 1 Million Shares on ASX - TipRanks

HeraMED Ltd. Issues 1 Million Shares on ASX TipRanks

Why HeraMED Limited (1I4) stock could be next leader - Trade Risk Assessment & Stepwise Swing Trade Plans - Trung tâm Dự báo KTTV quốc gia

Why HeraMED Limited (1I4) stock could be next leader - Trade Risk Assessment & Stepwise Swing Trade Plans Trung tâm Dự báo KTTV quốc gia

HeraMED Appoints Dr. Sharon Howell to Board, Strengthening Global Strategy - TipRanks

HeraMED Appoints Dr. Sharon Howell to Board, Strengthening Global Strategy TipRanks

HeraMED's A$2M Placement & 2025 Quarterly Report Impact - Stocks Down Under

HeraMED's A$2M Placement & 2025 Quarterly Report Impact Stocks Down Under

Is HeraMED Limited (1I4) stock good for long term investing - Weekly Investment Recap & High Accuracy Swing Trade Signals - Trung tâm Dự báo KTTV quốc gia

Is HeraMED Limited (1I4) stock good for long term investing - Weekly Investment Recap & High Accuracy Swing Trade Signals Trung tâm Dự báo KTTV quốc gia

HeraMED completes further $1 million institutional placement - BiotechDispatch

HeraMED completes further $1 million institutional placement BiotechDispatch

Gold Coast Hospital to try out HeraMED's remote pregnancy monitoring platform - Healthcare IT News

Gold Coast Hospital to try out HeraMED's remote pregnancy monitoring platform Healthcare IT News

HeraMED Ltd. Appoints New Director with Significant Securities Holdings - TipRanks

HeraMED Ltd. Appoints New Director with Significant Securities Holdings TipRanks

HeraMED gets $1m from big investors - The Australian

HeraMED gets $1m from big investors The Australian

Will HeraMED Limited (1I4) stock sustain bullish trend into 2025 - Market Growth Summary & Technical Buy Zone Confirmation - Trung tâm Dự báo KTTV quốc gia

Will HeraMED Limited (1I4) stock sustain bullish trend into 2025 - Market Growth Summary & Technical Buy Zone Confirmation Trung tâm Dự báo KTTV quốc gia

Israeli dad invents fetal heart rate monitor for home use - Unpacked

Israeli dad invents fetal heart rate monitor for home use Unpacked

Why HeraMED Limited (1I4) stock stays resilient - Trade Risk Report & AI Enhanced Trade Execution Alerts - newser.com

Why HeraMED Limited (1I4) stock stays resilient - Trade Risk Report & AI Enhanced Trade Execution Alerts newser.com

Stocks of the Hour: Prospech, Hera Med, LCL Resources - Sharecafe

Stocks of the Hour: Prospech, Hera Med, LCL Resources Sharecafe

Will HeraMED Limited (1I4) stock sustain bullish trend into 2025 - July 2025 Update & Accurate Trade Setup Notifications - Trung tâm Dự báo KTTV quốc gia

Will HeraMED Limited (1I4) stock sustain bullish trend into 2025 - July 2025 Update & Accurate Trade Setup Notifications Trung tâm Dự báo KTTV quốc gia

HeraMED’s maternity care digital revolution - The Australian

HeraMED’s maternity care digital revolution The Australian

Why HeraMED Limited (1I4) stock stays resilient - July 2025 Sector Moves & Risk Controlled Stock Alerts - newser.com

Why HeraMED Limited (1I4) stock stays resilient - July 2025 Sector Moves & Risk Controlled Stock Alerts newser.com

4 emerging technologies to take the worry out of pregnancy - Unpacked

4 emerging technologies to take the worry out of pregnancy Unpacked

New AI tool for detecting facial palsy and more briefs - Mobi Health News

New AI tool for detecting facial palsy and more briefs Mobi Health News

ALERT: Price-sensitive ASX Announcement for HMD - intelligentinvestor.com.au

ALERT: Price-sensitive ASX Announcement for HMD intelligentinvestor.com.au

No More Invasive Tests: Hera Biotech’s Endometriosis Solution - Forbes

No More Invasive Tests: Hera Biotech’s Endometriosis Solution Forbes

HeraMED’s new age technology addresses age-old problems - iTWire

HeraMED’s new age technology addresses age-old problems iTWire

ASX Health Stocks: Paradigm Bio says drug effective in dogs, HeraMED signs deal in US - Stockhead

ASX Health Stocks: Paradigm Bio says drug effective in dogs, HeraMED signs deal in US Stockhead

HeraMED files NIS 16m prospectus in Australia - Globes - Israel Business News

HeraMED files NIS 16m prospectus in Australia Globes - Israel Business News

Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer - The New England Journal of Medicine

Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer The New England Journal of Medicine

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant